Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Adrenal Insufficiency × 1 year × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 296 Neoplasms 249 Carcinoma, Non-Small-Cell Lung 175 Colorectal Neoplasms 149 Prostatic Neoplasms 136 Lung Neoplasms 133 Carcinoma, Hepatocellular 108 Multiple Myeloma 87 Leukemia, Myeloid, Acute 71 Stomach Neoplasms 66 Pancreatic Neoplasms 66 Uterine Cervical Neoplasms 60 Recurrence 60 Neoplasm Metastasis 60 Rectal Neoplasms 59 Squamous Cell Carcinoma of Head and Neck 56 Ovarian Neoplasms 55 Glioblastoma 51 Small Cell Lung Carcinoma 49 Head and Neck Neoplasms 48 Brain Neoplasms 48 Triple Negative Breast Neoplasms 45 Precursor Cell Lymphoblastic Leukemia-Lymphoma 44 Glioma 42 Endometrial Neoplasms 40 Esophageal Neoplasms 39 Colonic Neoplasms 38 Carcinoma, Renal Cell 37 Urinary Bladder Neoplasms 35 Disease 35

Interventions

ravulizumab 1 Prednisone 1 Prednisolone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07221838 2026-03-03

OCTAGON

Alexion Pharmaceuticals, Inc.

Phase 4 Not yet recruiting

Adrenal Insufficiency, Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡